Alzheimer's Disease: a Mini-review for the Clinician

Overview

Journal Front Neurol

Specialty Neurology

Date 2023 Jul 10

PMID 37426432

Authors

Rishi S Madnani

Affiliations

Soon will be listed here.

Abstract

Alzheimer's disease (AD), the most common form of dementia, is a striking example of the connection between neurophysiological abnormalities and higher-order cognitive deficiencies. Since its initial description in 1906, research into the pathophysiology and etiology of AD has led to the illumination of an incredibly complex set of genetic and molecular mechanisms for the disease's progression, characterized by much more than the neuropathological hallmarks of beta-amyloid (Aβ) plaques and neurofibrillary tangles (NFTs). In this review, findings relating the neurodegeneration present in AD to its clinical presentation and treatment are summarized, with an emphasis on the interconnectedness of disease pathophysiology. Further, diagnostic guidelines are provided based on the National Institute on Aging-Alzheimer's Association (NIA-AA) workgroup's clinical recommendations. Through the dissemination of detailed but digestible open access resources such as this one, we can move towards an increase in the equity and accessibility of education for the modern clinician.

Citing Articles

Retinal dysfunction in APOE4 knock-in mouse model of Alzheimer's disease.

Abhyankar S, Luo Q, Hartman G, Mahajan N, Corson T, Oblak A Alzheimers Dement. 2025; 21(2):e14433.

PMID: 39749840 PMC: 11848189. DOI: 10.1002/alz.14433.

Neuroprotective Effects of STAT3 Inhibitor on Hydrogen Peroxide-Induced Neuronal Cell Death via the ERK/CREB Signaling Pathway.

Kim S, Kwon Y, Seo E, Lee H, Sohn J, Shin H Neurochem Res. 2024; 50(1):52.

PMID: 39648181 PMC: 11625690. DOI: 10.1007/s11064-024-04252-3.

The Misdiagnosis and Underdiagnosis of Hepatic Encephalopathy.

Bloom P Clin Transl Gastroenterol. 2024; 16(2):e00784.

PMID: 39635997 PMC: 11845192. DOI: 10.14309/ctg.0000000000000784.

Application of mesenchymal stem cells for neurodegenerative diseases therapy discovery.

Trinh Q, Mai H, Pham D Regen Ther. 2024; 26:981-989.

PMID: 39524179 PMC: 11550585. DOI: 10.1016/j.reth.2024.09.014.

Apolipoprotein E and Alzheimer's Disease in Italian Population: Systematic Review and Meta-Analysis.

Abrego-Guandique D, Saraceno G, Cannataro R, Manzzo de Burnside M, Caroleo M, Cione E Brain Sci. 2024; 14(9).

PMID: 39335404 PMC: 11430190. DOI: 10.3390/brainsci14090908.

References

Alonso A, Zaidi T, Grundke-Iqbal I, Iqbal K . Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease. Proc Natl Acad Sci U S A. 1994; 91(12):5562-6. PMC: 44036. DOI: 10.1073/pnas.91.12.5562. View

Seaks C, Wilcock D . Infectious hypothesis of Alzheimer disease. PLoS Pathog. 2020; 16(11):e1008596. PMC: 7660461. DOI: 10.1371/journal.ppat.1008596. View

Bamburg J, Bloom G . Cytoskeletal pathologies of Alzheimer disease. Cell Motil Cytoskeleton. 2009; 66(8):635-49. PMC: 2754410. DOI: 10.1002/cm.20388. View

Breijyeh Z, Karaman R . Comprehensive Review on Alzheimer's Disease: Causes and Treatment. Molecules. 2020; 25(24). PMC: 7764106. DOI: 10.3390/molecules25245789. View

Nguyen T, Hoai Ta Q, Nguyen T, Le T, Vo V . Role of Insulin Resistance in the Alzheimer's Disease Progression. Neurochem Res. 2020; 45(7):1481-1491. DOI: 10.1007/s11064-020-03031-0. View

Zanetti O, Solerte S, Cantoni F . Life expectancy in Alzheimer's disease (AD). Arch Gerontol Geriatr. 2009; 49 Suppl 1:237-43. DOI: 10.1016/j.archger.2009.09.035. View

Roher A, Lowenson J, Clarke S, Woods A, Cotter R, Gowing E . beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease. Proc Natl Acad Sci U S A. 1993; 90(22):10836-40. PMC: 47873. DOI: 10.1073/pnas.90.22.10836. View

Churchwell K, Elkind M, Benjamin R, Carson A, Chang E, Lawrence W . Call to Action: Structural Racism as a Fundamental Driver of Health Disparities: A Presidential Advisory From the American Heart Association. Circulation. 2020; 142(24):e454-e468. DOI: 10.1161/CIR.0000000000000936. View

Mroczko B, Groblewska M, Litman-Zawadzka A, Kornhuber J, Lewczuk P . Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer's Disease. Int J Mol Sci. 2018; 19(7). PMC: 6073792. DOI: 10.3390/ijms19071884. View

10.

The Lancet . Lecanemab for Alzheimer's disease: tempering hype and hope. Lancet. 2022; 400(10367):1899. DOI: 10.1016/S0140-6736(22)02480-1. View

11.

Sengupta A, Kabat J, Novak M, Wu Q, Grundke-Iqbal I, Iqbal K . Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules. Arch Biochem Biophys. 1998; 357(2):299-309. DOI: 10.1006/abbi.1998.0813. View

12.

Hampel H, Burger K, Teipel S, Bokde A, Zetterberg H, Blennow K . Core candidate neurochemical and imaging biomarkers of Alzheimer's disease. Alzheimers Dement. 2008; 4(1):38-48. DOI: 10.1016/j.jalz.2007.08.006. View

13.

Stern Y . Cognitive reserve in ageing and Alzheimer's disease. Lancet Neurol. 2012; 11(11):1006-12. PMC: 3507991. DOI: 10.1016/S1474-4422(12)70191-6. View

14.

Ricciarelli R, Fedele E . The Amyloid Cascade Hypothesis in Alzheimer's Disease: It's Time to Change Our Mind. Curr Neuropharmacol. 2017; 15(6):926-935. PMC: 5652035. DOI: 10.2174/1570159X15666170116143743. View

15.

Hoover B, Reed M, Su J, Penrod R, Kotilinek L, Grant M . Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron. 2010; 68(6):1067-81. PMC: 3026458. DOI: 10.1016/j.neuron.2010.11.030. View

16.

Golde T . Alzheimer's disease - the journey of a healthy brain into organ failure. Mol Neurodegener. 2022; 17(1):18. PMC: 8898417. DOI: 10.1186/s13024-022-00523-1. View

17.

Farrer L, Cupples L, Haines J, Hyman B, Kukull W, Mayeux R . Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA. 1997; 278(16):1349-56. View

18.

Alzheimer A, Stelzmann R, SCHNITZLEIN H, Murtagh F . An English translation of Alzheimer's 1907 paper, "Uber eine eigenartige Erkankung der Hirnrinde". Clin Anat. 1995; 8(6):429-31. DOI: 10.1002/ca.980080612. View

19.

Kinney J, Bemiller S, Murtishaw A, Leisgang A, Salazar A, Lamb B . Inflammation as a central mechanism in Alzheimer's disease. Alzheimers Dement (N Y). 2018; 4:575-590. PMC: 6214864. DOI: 10.1016/j.trci.2018.06.014. View

20.

Albert M, DeKosky S, Dickson D, Dubois B, Feldman H, Fox N . The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011; 7(3):270-9. PMC: 3312027. DOI: 10.1016/j.jalz.2011.03.008. View